Literature DB >> 12747873

Enfuvirtide, a new drug for HIV infection.

Courtney V Fletcher1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12747873     DOI: 10.1016/S0140-6736(03)13323-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development.

Authors:  Antonella Castagna; Priscilla Biswas; Alberto Beretta; Adriano Lazzarin
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Targeting protein-protein interactions by rational design: mimicry of protein surfaces.

Authors:  Steven Fletcher; Andrew D Hamilton
Journal:  J R Soc Interface       Date:  2006-04-22       Impact factor: 4.118

3.  Function-oriented development of CXCR4 antagonists as selective human immunodeficiency virus (HIV)-1 entry inhibitors.

Authors:  Chien-Huang Wu; Chuan-Jen Wang; Chun-Ping Chang; Yung-Chi Cheng; Jen-Shin Song; Jiing-Jyh Jan; Ming-Chen Chou; Yi-Yu Ke; Jing Ma; Ying-Chieh Wong; Tsung-Chih Hsieh; Yun-Chen Tien; Elizabeth A Gullen; Chen-Fu Lo; Chia-Yi Cheng; Yu-Wei Liu; Amit A Sadani; Chia-Hua Tsai; Hsin-Pang Hsieh; Lun K Tsou; Kak-Shan Shia
Journal:  J Med Chem       Date:  2015-01-28       Impact factor: 7.446

4.  Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein.

Authors:  Matteo Porotto; Ilaria Devito; Samantha G Palmer; Eric M Jurgens; Jia L Yee; Christine C Yokoyama; Antonello Pessi; Anne Moscona
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

5.  Enzymatic glycosylation of triazole-linked GlcNAc/Glc-peptides: synthesis, stability and anti-HIV activity of triazole-linked HIV-1 gp41 glycopeptide C34 analogues.

Authors:  Wei Huang; Stan Groothuys; Alonso Heredia; Brian H M Kuijpers; Floris P J T Rutjes; Floris L van Delft; Lai-Xi Wang
Journal:  Chembiochem       Date:  2009-05-04       Impact factor: 3.164

6.  Sulfono-γ-AA modified peptides that inhibit HIV-1 fusion.

Authors:  Olapeju Bolarinwa; Meng Zhang; Erin Mulry; Min Lu; Jianfeng Cai
Journal:  Org Biomol Chem       Date:  2018-10-31       Impact factor: 3.876

Review 7.  Pharmacological inhibition of feline immunodeficiency virus (FIV).

Authors:  Hakimeh Mohammadi; Dorothee Bienzle
Journal:  Viruses       Date:  2012-04-27       Impact factor: 5.048

Review 8.  Peptide-based Fusion Inhibitors for Preventing the Six-helix Bundle Formation of Class I Fusion Proteins: HIV and Beyond.

Authors:  Ajit Monteiro; Karl O A Yu; Mark D Hicar
Journal:  Curr HIV Res       Date:  2021       Impact factor: 1.341

9.  IgG Fc-binding motif-conjugated HIV-1 fusion inhibitor exhibits improved potency and in vivo half-life: Potential application in combination with broad neutralizing antibodies.

Authors:  Wenwen Bi; Wei Xu; Liang Cheng; Jing Xue; Qian Wang; Fei Yu; Shuai Xia; Qi Wang; Guangming Li; Chuan Qin; Lu Lu; Lishan Su; Shibo Jiang
Journal:  PLoS Pathog       Date:  2019-12-05       Impact factor: 6.823

10.  Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum.

Authors:  Belén Martínez-Gualda; Liang Sun; Olaia Martí-Marí; Carmen Mirabelli; Leen Delang; Johan Neyts; Dominique Schols; María-José Camarasa; Ana San-Félix
Journal:  Antiviral Res       Date:  2019-06-20       Impact factor: 5.970

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.